BridgeMD
Compares treatment options for Metastatic Spinal Cord Compression
Official title To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway
ClinicalTrials.gov ID: NCT06965101
What this study is testing
- What it's testing
- The goal of this clinical trial is to understand whether the Magnetic Resonance Linear Accelerator (MRL) could expedite Radiotherapy treatment for Metastatic Cord Compression (MSCC) by removing the need for a planning CT (pCT) scan prior to treatment. Radiotherapy will be delivered in one appointment on the MRL and compared to the standard of care of two appointments: a CT scan and a Radiotherapy appointment.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Confirmed Diagnosis of MSCC
- Referred for an 8Gy, Single Fraction of Radiotherapy
- 18 years or older.
- Able to give informed consent in writing or verbally.
- Willing to complete patient experience questionnaire
You likely can't join if
- Participant does not have capacity and cannot give informed consent.
- Any evidence of significant clinical disorder or laboratory finding which, in the opinion of the investigator, make it undesirable for the patient to...
- Participant is unwilling to allow researchers to access their clinical notes and diagnostic scans.
- Participant is unwilling to complete an experience questionnaire
- The participant cannot speak or understand English. Exclusion Criteria MRL arm:
- Any contraindications to MRI identified after MRI safety screening
See the full eligibility criteria
- Confirmed Diagnosis of MSCC
- Referred for an 8Gy, Single Fraction of Radiotherapy
- 18 years or older.
- Able to give informed consent in writing or verbally.
- Willing to complete patient experience questionnaire
- Willing to have the research team review their case notes for up to 1 year following
- Participant does not have capacity and cannot give informed consent.
- Any evidence of significant clinical disorder or laboratory finding which, in the opinion of the investigator, make it undesirable for the patient to participate in the study.
- Participant is unwilling to allow researchers to access their clinical notes and diagnostic scans.
- Participant is unwilling to complete an experience questionnaire
- The participant cannot speak or understand English. Exclusion Criteria MRL arm:
- Any contraindications to MRI identified after MRI safety screening
- Unable to tolerate MRI scanning
- Uncontrolled pain/ poor pain control.
- MSCC in the cervical spine.
- More than one vertebral level of compression
The study team makes the final eligibility decision.
Where it's taking place
- Manchester, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Manchester, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.